Newsroom

Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022
08.07.2022
“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices
06.30.2022
Experts Unveil Recommendations For Transforming 911
06.29.2022
Statement from Mark E. Miller on Medicare Advantage Oversight Hearing
06.27.2022
Statement from Mark E. Miller on New Insulin Legislation Offered in Senate
06.23.2022
Study: Misdemeanor Diversion Produces Public Safety & Cost Benefits
04.14.2022
Study: Intensive, Specialized Training of Police Officers Leads to Reduced Crime, Fewer Arrests, and More Positive Interactions and Community Evaluations
03.29.2022
Collaborative Project Launches Exploration of Reform in College Sports
03.24.2022
Statement from Arnold Ventures’ Mark Miller on Federal Judge’s Ruling on Surprise Billing Arbitration Process
02.24.2022
Statement from Arnold Ventures’ Kelly McManus on Support of the College Transparency Act in the House
02.04.2022
Arnold Ventures’ Statement on the Expansion of Earned Time Credits Under the First Step Act
01.13.2022
Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework
10.28.2021
No Surprises Act Implementation Positive Sign for Patients Hurt By Surprise Bills
10.01.2021
A Statement From Arnold Ventures’ Kelly McManus on the Retention and Completion Fund in the Build Back Better Act
09.08.2021
Arnold Ventures’ Statement on Medicare Trustees Report
09.01.2021
Arnold Ventures’ Statement on Extended Debt Relief for Students Who Attended ITT Tech
08.26.2021
Arnold Ventures’ Statement on No Surprises Act Final Rule
07.01.2021
A Statement from Arnold Ventures on Surprise Medical Billing Legislation
12.22.2020

Media Inquiries

If you are a member of the media, contact us via email at media@arnoldventures.org. Please include your name, media outlet affiliation, contact information, questions, and deadline.